Healthcare conglomerate Johnson & Johnson (NYSE: JNJ ) is arguably the mantelpiece healthcare company all investors look up to.
With the exception of Novartis, which is currently dueling neck-and-neck with J&J for the highest market valuation among healthcare stocks, Johnson & Johnson is the unrivaled company that tends to set the tone through the sector come earnings season. As one of the largest healthcare companies, it’s also looked up to by income-seekers and risk-averse investors who count on J&J’s above-average dividend yield; its steady profits, which derive from its three business segments (consumer health, medical devices, and pharmaceuticals); and its lack of volatility. Johnson & Johnson shareholders get the luxury of a good night’s sleep each night, which isn’t something select biotech investors can attest to.
Hey, check out all the research scientist jobs. Post your resume today!
